XML 51 R25.htm IDEA: XBRL DOCUMENT v3.24.4
Income Taxes
12 Months Ended
Oct. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

15. Income Taxes

Loss before provision for income taxes consisted of the following:

 

 

Year ended October 31,

 

 

2024

 

 

2023

 

Domestic (Canada)

 

$

(53,460

)

 

$

(99,157

)

Foreign (US)

 

 

(1,701

)

 

 

(743

)

Loss before income taxes

 

$

(55,161

)

 

$

(99,900

)

 

The components of the provision for (recovery of) income taxes is as follows:

 

 

Year ended October 31,

 

 

2024

 

 

2023

 

Current expense (benefit):

 

 

 

 

 

 

Domestic (Canada)

 

$

 

 

$

 

Foreign (US)

 

 

(19

)

 

 

17

 

Total current expense (benefit)

 

 

(19

)

 

 

17

 

 

 

 

 

 

 

 

Deferred expense (benefit)

 

 

 

 

 

 

Domestic (Canada)

 

 

 

 

 

 

Foreign (US)

 

 

 

 

 

 

Total deferred tax expense (benefit)

 

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense (benefit)

 

$

(19

)

 

$

17

 

 

A reconciliation of the Company's statutory income tax rate to the Company's effective income tax rate is as follows:

 

 

Year ended October 31,

 

 

2024

 

 

2023

 

Income at Canadian statutory rate

 

 

26.50

%

 

 

26.50

%

Conversion of debentures

 

 

 

 

 

(21.90

)%

State taxes, net of federal benefit

 

 

0.18

%

 

 

0.05

%

Permanent differences

 

 

(2.77

)%

 

 

1.68

%

Tax credits

 

 

1.07

%

 

 

0.19

%

Foreign rate differential

 

 

(0.17

)%

 

 

(0.04

)%

Valuation allowance

 

 

(25.02

)%

 

 

(6.52

)%

Other

 

 

0.24

%

 

 

0.03

%

 

 

0.03

%

 

 

(0.01

)%

 

The net deferred income tax balances related to the following:

 

 

 

October 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

R&D expenditures

 

 

8,172

 

 

 

7,012

 

Net operating loss (NOL) carryforwards

 

 

31,661

 

 

 

18,918

 

Capital loss carryforwards

 

 

97

 

 

 

 

Investment tax credits, net

 

 

1,934

 

 

 

1,210

 

Property and equipment

 

 

704

 

 

 

791

 

Financing costs

 

 

5,452

 

 

 

2,440

 

Accruals

 

 

747

 

 

 

149

 

Section 174 capitalized R&D costs

 

 

 

 

 

393

 

Operating lease liability

 

 

404

 

 

 

 

Note payable

 

 

197

 

 

 

 

Other

 

 

1

 

 

 

172

 

Total deferred tax assets

 

 

49,369

 

 

 

31,085

 

Deferred tax liabilities:

 

 

 

 

 

 

Operating lease-right of use asset

 

 

(377

)

 

 

 

Total deferred tax liabilities

 

 

(377

)

 

 

 

Valuation allowance

 

 

(48,992

)

 

 

(31,085

)

Net deferred tax assets (liability)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations for both federal taxes and the provinces and states in which the Company operates or does business in. ASC 740 states that a tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, on the basis of the technical merits.

The Company records uncertain tax positions as liabilities in accordance with ASC 740 and adjusts these liabilities when the Company’s judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from the current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. As of October 31, 2024 and 2023, no uncertain tax positions have been recorded in the consolidated financial statements.

The Company recognizes interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying consolidated statement of operations and comprehensive loss. As of October 31, 2024 and 2023, no accrued interest or penalties are included on the related tax liability line in the consolidated balance sheet.

As of October 31, 2024, the Company has Canadian Federal NOL carryforwards of $119.1 million, that expire between 2026 and 2044 and Canadian provincial NOL carryforwards of $113.1 million, that expire between 2029 and 2044. These losses are available to offset future taxable income in Canada and Quebec. As of October 31, 2024, the Company has a U.S. Federal NOL carryforward of $1.9 million, that may be carried forward indefinitely, and a U.S. state NOL carryforward of $1.4 million, which are available to offset against future taxable income in the U.S and Massachusetts. The U.S. State tax loss carryforward will expire between 2041 and 2043. The Company has not recognized the tax benefit of these losses.

As of October 31, 2024, the Company also has non-refundable Canadian investment tax credits of $2.6 million that expire between 2025 and 2044. These credits may be utilized to reduce Canadian federal income taxes payable. The Company has not recognized the tax benefits related to these non-refundable investment tax credits.

As of October 31, 2024, the Company also has capital losses of $0.7 million which are available to be used indefinitely against future capital gains.

As of October 31, 2023, the Company had SR&ED expenditures of approximately $29.6 million for Canadian federal purposes and $32.5 million for Québec provincial purposes, which have not been deducted. These expenditures are available to reduce future taxable income and have an unlimited carryforward period. SR&ED expenditures are subject to verification by the tax authorities and, accordingly, the amounts may vary.